Concepedia

Sharon A. Baughman

SA

Statistics

Publications

8

Citations

3K

H-Index

8

Active since

1992

Affiliations

Cytokinetics (United States)(Current)

Memorial Sloan Kettering Cancer Center

Sharon A. Baughman is an author at Cytokinetics (United States) specializing in pharmacology, medicine, and pharmacokinetics.

Publications per year

1992–2007

8

Publications

8

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, John Mendelsohn et al. · Journal of Clinical Oncology · 1996 · 1.4K citations

, , +17

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.

Mark D. Pegram, A. Lipton, Daniel F. Hayes et al. · Journal of Clinical Oncology · 1998 · 1.1K citations

, , +17

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, J. Mendelsohn et al. · PubMed · 1999 · 300 citations

, , +16

Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys

Andrew J. S. Jones, Damon I. Papac, Edward Chin et al. · Glycobiology · 2007 · 135 citations · Full text

, , +17

Percutaneous absorption of co-administered N-methyl-2-[14C]pyrrolidinone and 2-[14C]pyrrolidinone in the rat

I. Midgley, Ashley J. Hood, L. F. Chasseaud et al. · Food and Chemical Toxicology · 1992 · 26 citations

, , +10

1–5 of 8